BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gao Z, Wang XY, Shen ZG, Liu JH, Wang XY, Wu SK, Jin X. Real-world comparison of chemotherapy plus bevacizumab with or without immunotherapy as first-line therapy in colorectal cancer. World J Gastroenterol 2025; 31(24): 108298 [PMID: 40599189 DOI: 10.3748/wjg.v31.i24.108298]
URL: https://www.wjgnet.com/1007-9327/full/v31/i24/108298.htm
Number Citing Articles
1
Chang Zhang, Shi-Hao Wu, Lei Jin, Liang Lu, Ji Li, Shui Jin. Propensity score-based real-world study of immune checkpoint inhibitor combination therapy in microsatellite stable/proficient mismatch repair metastatic colorectal cancer. World Journal of Gastrointestinal Oncology 2026; 18(11): 124022 doi: 10.4251/wjgo.124022
2
Jiamin Lu, Yuqian Feng, Kaibo Guo, Hong Pan. Prognostic value of the systemic immune-inflammation index in gastrointestinal cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-05014-x